DIN 02547635 — TARO-PALBOCICLIB 75 MG
TARO-PALBOCICLIB is a tablet of Palbociclib marketed by TARO PHARMACEUTICALS INC. The full Palbociclib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02547635
- Brand name
- TARO-PALBOCICLIB
- Active ingredient
- Palbociclib
- Strength
- 75 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TARO PHARMACEUTICALS INC
- Health Canada status
- MARKETED
- Drug class
- Protein kinase inhibitor (CDK4/6 inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Palbociclib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02493543 | IBRANCE | 100 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02493551 | IBRANCE | 125 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02493535 | IBRANCE | 75 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02552132 | PMS-PALBOCICLIB | 100 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02552140 | PMS-PALBOCICLIB | 125 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02552124 | PMS-PALBOCICLIB | 75 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02547643 | TARO-PALBOCICLIB | 100 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |
| 02547651 | TARO-PALBOCICLIB | 125 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED |